Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & Wan Ling Neo
  • November 15, 2019
  • Articles

Launching novel oncology therapies in Asia: Identifying and communicating value

Launching novel oncology therapies in Asia: Identifying and communicating value

Novel cancer therapies are offering patients new treatments and better outcomes worldwide. Recent changes in healthcare policies across APAC have reignited interest in the region as a strong market for oncology, such as China's fast tracking approval of therapies for severe and rare diseases and Vietnam's plan to cover health insurance for 80% of the population. Unfortunately, the often eye-watering costs of these new therapies means that, currently, for the many patients who still have to pay for treatment out of pocket, novel therapies are beyong reach. Pharma brands need to demonstate clear value if they want to achieve success. 

read more »

  • Posted by Paul Reed & Rachel Howard
  • November 1, 2019
  • Webinars

Communication trends in Latin America: How pharma can utilise new and emerging digital platforms

Communication trends in Latin America: How pharma can utilise new and emerging digital platforms

Smartphones and digital technology have revolutionised the way we communicate with one another. Latin America, like other parts of the world, has been swift to embrace new and emerging digital applications, in particular WhatsApp, which has become an ubiquitous tool for people in both their personal lives and in business. As digital communication channels increase in popularity, it is important for the pharmaceutical industry to keep in step. Understanding how to leverage platforms like WhatsApp as both a means of generating customer insight and as a stakeholder engagement tool, will help pharma companies to have impact in this exciting and ever-changing region.

read more »

  • Posted by Rachel Howard
  • October 23, 2019
  • Articles

Market access in Brazil: All eyes on Spinraza

Market access in Brazil: All eyes on Spinraza

Director Rachel Howard asks, “What does Brazil’s unprecedented risk-sharing agreement in Spinal Muscular Atrophy (SMA) mean for the future of market access in Brazil?

In April 2019, Brazilian Health Minister Luiz Henrique Mandetta announced a pilot agreement for access to Biogen’s Spinal Muscular Atrophy (SMA) treatment Spinraza (nusinersen) through the Sistema Único de Saúde (SUS). This is the first agreement in Brazil to include a risk-sharing model, in which the government only pays for the drug if there is improvement in the patient's health. In a country where it typically takes years for innovative pharmaceutical products to be reimbursed in the public sector, manufacturers wishing to obtain market access for their products in Brazil will be watching this example closely to see how it plays out.

read more »

  • Posted by Pei Li Teh & Colin Tan
  • October 22, 2019
  • Events

Real world evidence research breakfast seminar

Real world evidence research breakfast seminar

We were delighted to attend and present a paper at the Tech Observer event in Singapore earlier this month

APAC Director Pei Li Teh, and Research Manager, Colin Tan, attended the event. Pei Li presented the paper ‘Inhale, exhale: How using real world data helped asthma patients breathe easier across Asia’. In her paper she demonstrated how published real world data research provided pharma companies with an in-depth understanding of asthma patients’ across Asia. The data provided the healthcare community with a tool to supply tailored communications supporting different patient types, instead of a ‘one size fits all’ approach.

read more »

  • Posted by Pei Li Teh
  • October 21, 2019
  • News

Research Partnership welcomes Jeanne Penn

Research Partnership welcomes Jeanne Penn

We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.

Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.

read more »